Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intrathecal baclofen for motor disorders

R D Penn1, J M Gianino, M M York

  • 1Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA.

Movement Disorders : Official Journal of the Movement Disorder Society
|September 1, 1995
PubMed
Summary

Intrathecal baclofen effectively treated movement disorders like spasticity and painful spasms in 18 patients. Ten patients received long-term treatment via infusion pumps, showing positive outcomes for specific conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

Neurology·2003
Same author

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·2001
Same author

Internal globus pallidotomy in dystonia secondary to Huntington's disease.

Movement disorders : official journal of the Movement Disorder Society·2000
Same author

Long-term testing of an intracranial pressure monitoring device.

Journal of neurosurgery·2000
Same author

Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease.

Brain and cognition·2000
Same author

Adverse effects associated with the intrathecal administration of ziconotide.

Pain·2000

Area of Science:

  • Neurology
  • Neurosurgery
  • Rehabilitation Medicine

Background:

  • Movement disorders encompass a range of conditions affecting motor control.
  • Intrathecal baclofen is a treatment option for severe spasticity and movement-related symptoms.
  • Evaluating its efficacy across diverse neurological conditions is crucial.

Purpose of the Study:

  • To assess the effectiveness of intrathecal baclofen in patients with various movement disorders.
  • To identify patient subgroups that benefit most from this therapeutic intervention.

Main Methods:

  • A trial of intrathecal baclofen was conducted in 18 patients.
  • Patients presented with conditions including dystonia, head trauma, cerebral palsy, rigidity, and painful spasms.
  • Successful trial participants proceeded to permanent intrathecal pump implantation for long-term management.

Related Experiment Videos

Main Results:

  • Patients with spasticity, painful spasms, or focal dystonias showed the most significant improvement.
  • No positive response was observed in patients with rigidity secondary to anoxic encephalopathy.
  • Ten out of eighteen patients were deemed suitable for long-term intrathecal baclofen therapy.

Conclusions:

  • Intrathecal baclofen is a viable and effective treatment for specific types of movement disorders, particularly those involving spasticity and painful spasms.
  • Patient selection is critical, as efficacy varies based on the underlying etiology of the movement disorder.
  • Long-term intrathecal baclofen therapy via infusion pumps can provide sustained relief for selected patients.